Open original FDA record ↗Recall record
- FDA identifier
- Z-2023-2024
- Company in FDA record
- Becton Dickinson & Co.
- FDA classification date
- Jun 5, 2024
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Assays may produce false negative results due to decreased activity of the enzyme utilized in manufacturing.
Source facts
- Action
- Consignees were mailed and/or emailed an URGENT: Medical Device Product Correction notification, dated 5/7/24. The notification instructs consignees to immediately inspect their inventory for affected devices and destroy them per the consignee's destruction process, ensure the notification is read and understood, disseminate the notification to among those in your organization and customers who should be made aware, and return the completed Response Form to BD by email to BDRC22@bd.com or by fax to 312-949-0438. Consignees with any complaints can call 1-844-823-5433 or email productcomplaints@bd.com; consignees with any recall related questions can email BDRC22@bd.com.
- Initiated
- 2024-05-07
- Root cause
- Component design/selection
- Distribution
- Domestic: Nationwide Distribution; Foreign: AU, BR, BE, CA, CO, & JP.
- Recall number
- Z-2023-2024
- Recall status
- Open, Classified
- CDRH record ID
- 207672
- FDA classified
- 2024-06-05
- Recall event number
- 94599